No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Diagnostics & Research
Established in 1989 and headquartered in Vienne, France, Eurofins Cerep SA delivers a broad spectrum of drug discovery support to pharmaceutical and biotechnology enterprises across the globe. The company's specialized offerings include the management of chemical compounds, high-throughput screening capabilities, in vitro safety assessments, optimization of lead compounds (SAR profiling), in vitro ADME evaluations, and in vivo pharmacokinetic (PK) studies. Furthermore, it provides expert services in assay development and design. The organization, originally known as Cerep SA, officially adopted the name Eurofins Cerep SA in June 2014.
www.eurofins.com/fr-fr/cerepNo one on the platform currently holds ALECR.PA.
No tracked institution reports a position in ALECR.PA as of their last filing.
No one on the platform has traded ALECR.PA yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| ALECR.PAEurofins-Cerep S.A. | $16100.00 | +0.00% | $81M | — |
| AB.PAAB Science S.A. | $0.72 | -1.37% | $53M | — |
| AFME.PAAffluent Medical S.A. | $2.81 | +0.00% | $110M | — |
| ALBIO.PABiosynex S.A. | $0.92 | +2.00% | $17M | — |
| ALCJ.PACrossject S.A. | $1.31 | -5.22% | $78M | — |
| ALGAE.PAFermentalg | $0.47 | +1.29% | $56M | — |
| ALKLH.PAKlea Holding | $0.16 | +0.00% | $49M | — |
Source: Financial Modeling Prep · peers by sector/industry